During the past decade, Heubischer Strasse 39 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Heubischer Strasse 39" are "Tick-borne Encephalitis" (2 trials). Many other conditions were trialed in "Heubischer Strasse 39" in a lesser frequency.

Most popular intervention types in "Heubischer Strasse 39" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tick-borne Encephalitis Vaccine" (1 trials) and "Tick-borne encephalitis vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heubischer Strasse 39" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Heubischer Strasse 39". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Heubischer Strasse 39, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heubischer Strasse 39, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".